Autonomic cardiac modulation in obstructive sleep apnea: Effect of an oral jaw-positioning appliance

Chest

Volumn 130, Issue 5, 2006, Pages 1362-1368

  Coruzzi, Paolo ^a   Gualerzi, Massimo ^a,c   Bernkopf, Edoardo ^b   Brambilla, Lorenzo ^a   Brambilla, Valerio ^a   Broia, Vanna ^b   Lombardi, Carolina ^b   Parati, Gianfranco ^b  

^a UNIVERSITY OF PARMA   (Italy)

^b Prevention and Applied Biotechnologies ^*  (Italy)

^c IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

Autonomic nervous system; Cardiovascular prevention; Heart rate variability; Obstructive sleep apnea; Oral device

Indexed keywords

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE; FEMALE; FOLLOW UP; FREQUENCY MODULATION; HEART RATE VARIABILITY; HUMAN; LONG TERM CARE; MALE; PARASYMPATHETIC NERVE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REGULATORY MECHANISM; RR INTERVAL; SLEEP APNEA SYNDROME; SPLINT; STATISTICAL SIGNIFICANCE; SYMPATHETIC FUNCTION; TERAHERTZ SPECTROSCOPY; TREATMENT DURATION;

EID: 33751246783     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.130.5.1362     Document Type: Article

References (49)

1. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002; 165:1217-1239
2. Kales A, Bixler EO, Cadieux RJ, et al. Sleep apnoea in a hypertensive population. Lancet 1984; 2:1005-1008
3. Bradley TD, Floras JS. Sleep apnea and heart failure: part 1; Obstructive sleep apnea. Circulation 2003; 107:1671-1678
4. Hung J, Whitford EG, Parsons RW, et al. Association of sleep apnoea with myocardial infarction in men. Lancet 1990; 336:261-264
5. Dyken ME, Somers VK, Yamada T, et al. Investigating the relationship between stroke and obstructive sleep apnea. Stroke 1996; 27:401-4077
6. Narkiewicz K, Montano N, Cogliati C, et al. Altered cardiovascular variability in obstructive sleep apnea. Circulation 1998; 98:1071-1077
7. Kataoka M, Ito C, Sasaki H, et al. Low heart rate variability is a risk factor for sudden cardiac death in type 2 diabetes. Diabetes Res Clin Pract 2004; 64:51-58
8. Hadase M, Azuma A, Zen K, et al. Very low frequency power of heart rate variability is a powerful predictor of clinical prognosis in patients with congestive heart failure. Circ J 2004; 68:343-347
9. Kleiger RE, Miller JP, Bigger JT Jr, et al. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987; 59:256-262
10. Palatini P, Julius S. Heart rate and cardiovascular risk. J Hypertens 1997; 15:3-17
11. Coruzzi P, Parati G, Brambilla L, et al. Effects of salt sensitivity on neural cardiovascular regulation in essential hypertension. Hypertension 2005; 46:1321-1326
12. Dimsdale JE, Coy T, Ziegler MG, et al. The effect of sleep apnea on plasma and urinary catecholamines. Sleep 1995; 18:377-381
13. Somers VK, Dyken ME, Clary MP, et al. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995; 96:1897-1904
14. Pagani M, Lombardi F, Guzzetti S, et al. Power spectral analysis of heart rate and arterial pressure variability as a marker of simpatho-vagal interaction in man and conscious dog. Circ Res 1986; 59:178-193
15. Bonsignore MR, Parati G, Insalaco G, et al. Continuous positive airway pressure treatment improves baroreflex control of heart rate during sleep in severe obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2002; 166:279-286
16. Hedner J, Darpo B, Ejnell H, et al. Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications. Eur Respir J 1995; 8:222-229
17. Narkiewicz K, Kato M, Phillips BG, et al. Nocturnal continuous airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 1999; 100:2332-2335
18. Kato J, Isono S, Tanaka A, et al. Dose-dependent effects of mandibular advancement on pharyngeal mechanics and nocturnal oxygenation in patients with sleep-disordered breathing. Chest 2000; 117:1065-1072
19. Villa MP, Bernkopf E, Pagani J, et al. Randomized controlled study of an oral jaw-positioning appliance for the treatment of obstructive sleep apnea in children with malocclusion. Am J Respir Crit Care Med 2002; 165:123-127
20. Ferguson KA, Ono T, Lowe AA, et al. A short-term controlled trial of an adjustable oral appliance for the treatment of mild to moderate obstructive sleep apnoea. Thorax 1997; 52:362-368
21. Thorpy MJ, for the Diagnostic Classification Steering Committee. The international classification of sleep disorders: diagnostic and coding manual. Rochester, MN: American Sleep Disorders Association, 1990; 52-58
22. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 17:1230-1235
23. Akselrod S, Gordon D, Ubel FA, et al. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science 1981; 213:220-222
24. Cooley JW, Tukey JW. An algorithm for the machine computation of the complex Fourier series. Math Comput 1965; 19:297-301
25. Carlson JT, Hedner J, Elam M, et al. Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest 1993; 103:1763-1768
26. Singh JP, Larson MG, Tsuji H, et al. Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension; the Framingham Heart Study. Hypertension 1998; 32:293-297
27. Krieger J. Long-term compliance with nasal continuous positive airway pressure (CPAP) in obstructive sleep apnea patients and nonapneic snorers. Sleep 1992; 15:42-46
28. Ferguson KA, Cartwright R, Rogers R, et al. Oral appliances for snoring and obstructive sleep apnea: a review. Sleep 2006; 29:244-262
29. Engleman HM, McDonald JP, Graham D, et al. Randomized crossover trial of two treatments for sleep apnea/hypopnea syndrome: continuous positive airway pressure and mandibular repositioning splint. Am J Respir Crit Care Med 2002; 166:855-859
30. Schmidt-Nowara W, Lowe A, Wiegand L, et al. Oral appliances for the treatment of snoring and obstructive sleep apnea: a review. Sleep 1995; 18:501-510
31. Randerath WJ, Heise M, Hinz R, et al. An individually adjustable oral appliance vs continuous positive airway pressure in mild-to-moderate obstructive sleep apnea syndrome. Chest 2002; 122:569-575
32. Walker-Engstrom ML, Tegelberg A, Wilhelmsson B, et al. Four-year follow-up of treatment with dental appliance or uvulopalatopharyngoplasty in patients with obstructive sleep apnea: a randomized study. Chest 2002; 121:739-746
33. Liu Y, Zeng X, Fu M, et al. Effects of a mandibular repositioner on obstructive sleep apnea. Am J Orthod Dentofacial Orthop 2000; 118:248-256
34. Henke KG, Frantz DE, Kuna ST. An oral elastic mandibular advancement device for obstructive sleep apnea. Am J Respir Crit Care Med 2000; 161:420-425
35. Gao XM, Zeng XL, Fu MK, et al. Magnetic resonance imaging of the upper airway in obstructive sleep apnea before and after oral appliance therapy. Chin J Dent Res 1999; 2:27-35
36. Skinner MA, Robertson CJ, Kingshott RN, et al. The efficacy of a mandibular advancement splint in relation to cephalometric variables. Sleep Breath 2002; 6:115-124
37. Angle, EH. Classification of malocclusion. Dental Cosmos 1899; XLI:248-244, 350-357
38. Liu Y, Lowe AA, Fleetham JA, et al. Cephalometric and physiologic predictors of the efficacy of an adjustable oral appliance for treating obstructive sleep apnea. Am J Orthod Dentofacial Orthop 2001; 120:639-647
39. Pitsis AJ, Darendeliler MA, Gotsopoulos H, et al. Effect of vertical dimension on efficacy of oral appliance therapy in obstructive sleep apnea. Am J Respir Crit Care Med 2002; 15(6 Suppl):S42-S46
40. Neill A, Whyman R, Bannan S, et al. Mandibular advancement splint improves indices of obstructive sleep apnoea and snoring but side effects are common. N Z Med J 2002; 115:289-292
41. Kara T, Narkiewicz K, Somers VK. Chemoreflexes physiology and clinical implications. Acta Physiol Scand 2003; 177:377-384
42. Haight JS, Djupesland PG. Nitric oxide (NO) and obstructive sleep apnea (OSA). Sleep Breath 2003; 7:53-62
43. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 2000; 320:479-482
44. Fletcher EC. Cardiovascular effects of continuous positive airway pressure in obstructive sleep apnea. Sleep 2000; 23(suppl 4):S154-S157
45. Dimsdale JE, Loredo JS, Profant J. Effect of continuous positive airway pressure on blood pressure. Hypertension 2000; 35:144-147
46. Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003; 107:68-73
47. Yoshida K. Effect on blood pressure of oral appliance therapy for sleep apnea syndrome. Int J Prosthodont 2006; 19:61-66
48. Otsuka R, Ribeiro de Almeida F, Lowe AA, et al. The effect of oral appliance therapy on blood pressure in patients with obstructive sleep apnea. Sleep Breath 2006; 10:29-36
49. Brown TE, Beightol LA, Koh J, et al. Important influence of respiration on human R-R interval power spectra is largely ignored. J Appl Physiol 1993; 75:2310-2317